Items where Author is "Bill, Ruben"

2016

Lotz-Jenne, Carina and Lüthi, Urs and Ackerknecht, Sabine and Lehembre, François and Fink, Tobias and Stritt, Manuel and Wirth, Matthias and Pavan, Simona and Bill, Ruben and Regenass, Urs and Christofori, Gerhard and Meyer-Schaller, Nathalie. (2016) A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor. Oncotarget, 7 (18). pp. 25983-26002.

Pisarsky, Laura and Bill, Ruben and Fagiani, Ernesta and Dimeloe, Sarah and Goosen, Ryan William and Hagmann, Jörg and Hess, Christoph and Christofori, Gerhard. (2016) Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy. Cell Reports, 15 (6). pp. 1161-1174.

Bill, Ruben and Christofori, Gerhard. (2016) The Rip1Tag2 Transgenic Mouse Model. Methods in Molecular Biology, 1464. pp. 151-161.

Fagiani, Ernesta and Lorentz, Pascal and Bill, Ruben and Pavotbawan, Kirusigan and Kopfstein, Lucie and Christofori, Gerhard. (2016) VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue. Angiogenesis, 19 (3). pp. 339-358.

22 June 2015

Bill, Ruben and Christofori, Gerhard. (2015) The relevance of EMT in breast cancer metastasis: Correlation or causality? FEBS letters, 589 (14). pp. 1577-1587.

2015

Fagiani, Ernesta and Bill, Ruben and Pisarsky, Laura and Ivanek, Robert and Rüegg, Curzio and Christofori, Gerhard. (2015) An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models. Angiogenesis, Vol. 18 H. 3. pp. 327-345.

Bill, Ruben. Mechanisms of action and resistance to anti-angiogenic small-molecule tyrosine kinase inhibitors in preclinical breast cancer and pancreatic neuroendocrine tumor mouse models. 2015, Doctoral Thesis, University of Basel, Faculty of Science.

Bill, Ruben and Fagiani, Ernesta and Zumsteg, Adrian and Antoniadis, Helena and Johansson, David and Haefliger, Simon and Albrecht, Imke and Hilberg, Frank and Christofori, Gerhard. (2015) Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model. Clinical Cancer Research, 21 (21). pp. 4856-4867.